BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10229540)

  • 1. Cross-reactivity between six Enterobacteriaceae complete lipopolysaccharide core chemotypes.
    Nnalue NA; Khan GN; Mustafa N
    J Med Microbiol; 1999 May; 48(5):433-441. PubMed ID: 10229540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. alpha-GlcNAc-1-->2-alpha-glc, the Salmonella homologue of a conserved lipopolysaccharide motif in the Enterobacteriaceae, elicits broadly cross-reactive antibodies.
    Nnalue NA
    Infect Immun; 1998 Sep; 66(9):4389-96. PubMed ID: 9712792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The disaccharide L-alpha-D-heptose1-->7-L-alpha-D-heptose1-->of the inner core domain of Salmonella lipopolysaccharide is accessible to antibody and is the epitope of a broadly reactive monoclonal antibody.
    Nnalue NA; Lind SM; Lindberg AA
    J Immunol; 1992 Oct; 149(8):2722-8. PubMed ID: 1383323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies to enterobacterial common antigen and to Escherichia coli lipopolysaccharide outer core: demonstration of an antigenic determinant shared by enterobacterial common antigen and E. coli K5 capsular polysaccharide.
    Peters H; Jürs M; Jann B; Jann K; Timmis KN; Bitter-Suermann D
    Infect Immun; 1985 Nov; 50(2):459-66. PubMed ID: 2414223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharides.
    Di Padova FE; Brade H; Barclay GR; Poxton IR; Liehl E; Schuetze E; Kocher HP; Ramsay G; Schreier MH; McClelland DB
    Infect Immun; 1993 Sep; 61(9):3863-72. PubMed ID: 8359907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of enterobacterial common antigen by bacterial agglutination.
    Marx A; Petcovici M; Nacescu N; Mayer H; Schmidt G
    Infect Immun; 1977 Dec; 18(3):563-7. PubMed ID: 338482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to core lipopolysaccharide determinants: absence of cross-reactivity with heterologous lipopolysaccharides.
    Heumann D; Baumgartner JD; Jacot-Guillarmod H; Glauser MP
    J Infect Dis; 1991 Apr; 163(4):762-8. PubMed ID: 1707084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a cross-reactive epitope widely present in lipopolysaccharide from enterobacteria and recognized by the cross-protective monoclonal antibody WN1 222-5.
    Muller-Loennies S; Brade L; MacKenzie CR; Di Padova FE; Brade H
    J Biol Chem; 2003 Jul; 278(28):25618-27. PubMed ID: 12716894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralizing and cross-reactive antibodies against enterobacterial lipopolysaccharide.
    Müller-Loennies S; Brade L; Brade H
    Int J Med Microbiol; 2007 Sep; 297(5):321-40. PubMed ID: 17544324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-reaction between the genus-specific lipopolysaccharide antigen of Chlamydia spp. and the lipopolysaccharides of Porphyromonas gingivalis, Escherichia coli O119 and Salmonella newington: implications for diagnosis.
    Haralambieva I; Iankov I; Petrov D; Ivanova R; Kamarinchev B; Mitov I
    Diagn Microbiol Infect Dis; 2001 Nov; 41(3):99-106. PubMed ID: 11750161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequencies of lipopolysaccharide core types in Escherichia coli strains from bacteraemic patients.
    Appelmelk BJ; An YQ; Hekker TA; Thijs LG; MacLaren DM; de Graaf J
    Microbiology (Reading); 1994 May; 140 ( Pt 5)():1119-24. PubMed ID: 7517766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequencies of lipopolysaccharide core types among clinical isolates of Escherichia coli defined with monoclonal antibodies.
    Gibb AP; Barclay GR; Poxton IR; di Padova F
    J Infect Dis; 1992 Nov; 166(5):1051-7. PubMed ID: 1402016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural studies on the hexose region of the core in lipopolysaccharides from Enterobacteriaceae.
    Jansson PE; Lindberg AA; Lindberg B; Wollin R
    Eur J Biochem; 1981 Apr; 115(3):571-7. PubMed ID: 7016539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic and immunogenic differences in lipopolysaccharides of Escherichia coli J5 vaccine strains of different origins.
    Appelmelk BJ; Maaskant JJ; Verweij-van Vught AM; van der Meer NM; Thijs BG; MacLaren DM
    J Gen Microbiol; 1993 Nov; 139(11):2641-7. PubMed ID: 7506295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-reactivity of rabbit antibodies to lipopolysaccharides of Escherichia coli J5 and other gram-negative bacteria.
    Siber GR; Kania SA; Warren HS
    J Infect Dis; 1985 Nov; 152(5):954-64. PubMed ID: 2413146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of the common enterobacterial antigen produced by smooth and rough strains.
    Whang HY; Mayer H; Schmidt G; Neter E
    Infect Immun; 1972 Oct; 6(4):533-9. PubMed ID: 4564286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of serological specificity of anti-endotoxin sera directed against whole bacterial cells and core oligosaccharide of Escherichia coli J5-tetanus toxoid conjugate.
    Lukasiewicz J; Jachymek W; Niedziela T; Malik-Gebicka M; Dzieciatkowska M; Lugowski C
    Acta Biochim Pol; 2002; 49(3):721-34. PubMed ID: 12422242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-typical lipopolysaccharide core regions of some Hafnia alvei strains: structural and serological studies.
    Romanowska E; Katzenellenbogen E; Jachymek W; Niedziela T; Bogulska M; Lugowski C
    FEMS Immunol Med Microbiol; 1999 May; 24(1):63-71. PubMed ID: 10340714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-reactivity of monoclonal antibodies against lipopolysaccharides of gram-negative bacteria.
    de Jongh-Leuvenink J; Bouter AS; Marcelis JH; Schellekens J; Verhoef J
    Eur J Clin Microbiol; 1986 Apr; 5(2):148-51. PubMed ID: 2424754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological characterisation of anti-endotoxin sera directed against the conjugates of oligosaccharide core of Escherichia coli type R1, R2, R3, J5 and Salmonella Ra with tetanus toxoid.
    Lugowski C; Jachymek W; Niedziela T; Rowinski S
    FEMS Immunol Med Microbiol; 1996 Nov; 16(1):21-30. PubMed ID: 8954349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.